The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.

被引：0
|
作者：
Stewart, Grant
Laird, Alexander
O'Mahony, Fiach
Eory, Lel
Lubbock, Alexander
Nanda, Jyoti
O'Donnell, Marie
Mackay, Alan
Mullen, Peter
McNeill, Alan
Riddick, Antony
Aitchison, Michael
Berney, Daniel
Bex, Axel
Overton, Ian
Harrison, David James
Powles, Tom
机构：
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Roslin Inst, Edinburgh, Midlothian, Scotland
[3] MRC Human Genet Unit, Edinburgh, Midlothian, Scotland
[4] Royal Marsden NHS Fdn Trust, Inst Canc Res, London, England
[5] Univ St Andrews, St Andrews, Fife, Scotland
[6] Addenbrookes Hosp, Dept Urol, Cambridge CB2 2QQ, England
[7] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
[8] St Bartholomews Hosp, London, England
[9] Netherlands Canc Inst, Amsterdam, Netherlands
[10] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
[11] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
408
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Ezrin is a prognostic biomarker in patients with clear cell metastatic renal cell carcinoma receiving sunitinib
    Cetin, Bulent
    Gonul, Ipek Isik
    Gumusay, Ozge
    Afsar, Baris
    Bilgetekin, Irem
    Ozet, Ahmet
    Uner, Aytug
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (02) : 408 - 413
  • [32] Sequential FDG-PET/CT as a surrogate marker of response to sunitinib in metastatic clear cell renal cancer
    Powles, T.
    Chowdhury, S.
    Avril, N.
    Bomanji, J.
    Shamash, J.
    Sarwar, N.
    Rockall, A.
    Sahdev, A.
    Nathan, P. D.
    Kayani, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [33] Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
    Beuselinck, Benoit
    Job, Sylvie
    Becht, Etienne
    Karadimou, Alexandra
    Verkarre, Virginie
    Couchy, Gabrielle
    Giraldo, Nicolas
    Rioux-Leclercq, Nathalie
    Molinie, Vincent
    Sibony, Mathilde
    Elaidi, Reza
    Teghom, Corinne
    Patard, Jean-Jacques
    Mejean, Arnaud
    Fridman, Wolf Herman
    Sautes-Fridman, Catherine
    de Reynies, Aurelien
    Oudard, Stephane
    Zucman-Rossi, Jessica
    CLINICAL CANCER RESEARCH, 2015, 21 (06) : 1329 - 1339
  • [34] Metastatic clear cell renal cell carcinoma: Proangiogenic gene expression and outcome on sunitinib.
    Verbiest, Annelies
    Beuselinck, Benoit
    Couchy, Gabrielle
    Job, Sylvie
    De Reynies, Aurelien
    Meiller, Clement
    Albersen, Maarten
    Verkarre, Virginie
    Lerut, Evelyne
    Mejean, Arnaud
    Patard, Jean-Jacques
    Laguerre, Brigitte
    Rioux-Leclercq, Nathalie
    Schoffski, Patrick
    Oudard, Stephane
    Zucman-Rossi, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Effect of the timing of sunitinib administration on the predictive value of biomarkers in renal cell cancer (mRCC).
    Ebos, John Michael Louis
    Mastri, Michalis
    Hudson, John M.
    Lee, Christina R.
    Tracz, Amanda
    Attwood, Kristopher
    Burns, Peter N.
    Kerbel, Robert S.
    Bjarnason, Georg A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Identification of tumor biomarkers for sunitinib in advanced renal cell carcinoma (RCC)
    Dai, Hongyue
    Fishman, Mayer N.
    Ching, Keith A.
    Williams, James Andrew
    Teer, Jamie K.
    English, Patricia A.
    Zhang, Yonghong
    Murray, Brion W.
    Kumar, Naveen
    Huntsman, Shane
    Berglund, Anders E.
    Dalton, William S.
    Matczak, Ewa
    Martini, Jean-Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [37] A Phase II Study of Presurgical Sunitinib in Patients with Metastatic Clear-cell Renal Carcinoma and the Primary Tumor In Situ
    Bex, Axel
    Blank, Christian
    Meinhardt, Wim
    van Tinteren, Harm
    Horenblas, Simon
    Haanen, John
    UROLOGY, 2011, 78 (04) : 832 - 837
  • [38] Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
    D'Aniello, Carmine
    Berretta, Massimiliano
    Cavaliere, Carla
    Rossetti, Sabrina
    Facchini, Bianca Arianna
    Iovane, Gelsomina
    Mollo, Giovanna
    Capasso, Mariagrazia
    Della Pepa, Chiara
    Pesce, Laura
    D'Errico, Davide
    Buonerba, Carlo
    Di Lorenzo, Giuseppe
    Pisconti, Salvatore
    De Vita, Ferdinando
    Facchini, Gaetano
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [39] SUNITINIB IN ADVANCED CLEAR CELL RENAL CANCER: A SINGLE CENTRE EXPERIENCE
    Bruni, G. S.
    Facchini, G.
    Iaffaioli, V. R.
    Pisano, C.
    Pignata, S.
    EJC SUPPLEMENTS, 2008, 6 (14): : 123 - 123
  • [40] Asthenia and Fatigue as Potential Biomarkers of Sunitinib Efficacy in Metastatic Renal Cell Carcinoma
    Davis, M. P.
    Figlin, R. A.
    Hutson, T. E.
    Goldstein, D.
    Li, S.
    Perkins, J.
    Motzer, R. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S135 - S135
12345